Pharmaceutical Technology15h
Merative MarketScan
The FDA has released final draft recommendations for using real-world data and evidence in drug development.
Pharmaceutical Technology23h
AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit
AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
Pharmaceutical Technology23h
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Pharmaceutical Technology1d
Data Insights
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, ...